Executive Summary: Towards Improving Outcomes for Patients with ALS

First Page		Document Content
Date: 2014-01-08 16:32:31 Rare diseases Amyotrophic lateral sclerosis Riluzole Current Procedural Terminology Pseudobulbar palsy Pseudobulbar affect Patient safety ALS Association ALS Society of Canada Health Medicine Motor neurone disease		Executive Summary: Towards Improving Outcomes for Patients with ALS Add to Reading List Source URL: www.aan.com Download Document from Source Website File Size: 722,93 KB Share Document on Facebook

	Masitinib for amyotrophic lateral sclerosis – add-on therapy to riluzole DocID: 1gqBs - View Document
	Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole DocID: 17z0L - View Document
	Dear (Name of your Congressional and Senatorial Official at the Federal Level), I am writing to express interest in the approval status of a bio-drug produced by Genervon Biopharmaceuticals LLS, known as GM604 or GM6 DocID: 173Yp - View Document
	Executive Summary: Towards Improving Outcomes for Patients with ALS DocID: 14ZbG - View Document
	AMYOTROPHIC LATERAL SCLEROSIS (ALS) (also known as Lou Gehrig’s Disease) DISEASE FACT SHEET AND OPPORTUNITY FOR TIRASEMTIV What is ALS? About Us Cytokinetics is a clinical-stage biopharmaceutical company DocID: 13OuA - View Document